SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Conference Report 1991 Consensus development conference: Prophylaxis and treatment of osteoporosis. Osteoporosis Int 1: 114117
  • 2
    McBroom RJ, Hayes WC, Edwards WT, Goldberg RP, White AA 1985 Prediction of vertebral body compression fracture using quantitative computed tomography. J Bone Joint Surg Am 67: 12061214.
  • 3
    Dempster DW, Ferguson PM, Mellish RW, Cochran DV, Xie F, Fey C, Horbert W, Parisien M, Lindsay R 1993 Relationships between bone structure in the iliac crest and bone structure and strength in the lumbar spine. Osteoporos Int 3: 9096.
  • 4
    Genant HK, Gordon C, Jiang Y, Lang TF, Link TM, Majumdar S 1999 Advanced imaging of bone macro and micro structure. Bone 25: 149152.
  • 5
    Jiang Y, Zhao J, Van Audekercke R, Dequeker J, Geusens P 1996 Effects of low-dose long-term NaF preventive treatment on rat bone mass and biomechanical properties. Calcif Tissue Int 58: 3039.
  • 6
    Jiang Y, Zhao J, Van Audekercke R, Dequeker J, Geusens P 1997 Long-term effects of naproxen on bone mass and biomechanic properties of the femur and vertebral body of ovariectomized rats on normal or low calcium diet. J Bone Miner Res 19: 820831.
  • 7
    Jiang Y, Zhao J, Rosen C, Geusens P, Genant HK 1999 Perspectives on bone mechanical properties and adaptive response to mechanical challenge. J Clin Densitometry 2: 423433.
  • 8
    Geusens P 1992 Photon Absorptiometry in Osteoporosis: Bone Mineral Measurements in Animal Models and in Humans. Orientaliste, Leuven, Belgium.
  • 9
    Hochberg MC, Greenspan S, Wasnich RD, Miller P, Thompson DE, Ross PD 2002 Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents. J Clin Endocrinol Metab 87: 15861592.
  • 10
    Chesnut CH, Silverman S, Andriano K, Genant HK, Gimona A, Harris S, Kiel D, LeBoff M, Maricic M, Miller P, Moniz C, Peacock M, Richardson P, Watts N, Baylink D 2000 A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: The prevent recurrence of osteoporotic fractures study. Am J Med 109: 267276.
  • 11
    Black DM, Thompson DE, Bauer DC, Ensrud K, Musliner T, Hochberg MC, Nevitt MC, Suryawanshi S, Cummings SR 2000 Fracture risk reduction with alendronate in women with osteoporosis: The Fracture Intervention Trial. J Clin Endocrinol Metab 85: 41184124.
  • 12
    Cummings SR, Karpf DB, Harris F, Genant HK, Ensrud K, LaCroix AZ, Black DM 2002 Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med 112: 281289.
  • 13
    Sarkar S, Mitlak BH, Wong M, Stock JL, Black DM, Harper KD 2002 Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy. J Bone Miner Res 17: 110.
  • 14
    Chung H, Wehrili FW, Williams JL, Kugelmass SD 1993 Relationship between NMR transverse relaxation, trabecular bone architecture, and strength. Proc Natl Acad Sci USA 90: 1025010254.
  • 15
    Jiang Y, Zhao J, Genant HK 2002 Macro and micro imaging of bone architecture. In: BilezikianJP, RaiszLG, RodanGA (eds.) Principles of Bone Biology, 2nd ed. Academic Press, San Diego, CA, USA, pp. 15991623.
  • 16
    Jiang Y, Zhao J, Mitlak BH, Wang O, Genant HK, Eriksen EF 2003 Recombinant human parathyroid hormone (1–34) (teriparatide) improves both cortical and cancellous bone structure. J Bone Miner Res 18: 19321941.
  • 17
    Majumdar S, Newitt D, Jergas M, Gies A, Chiu E, Osman D, Keltner J, Keyak J, Genant HK 1995 Evaluation of technical factors affecting the quantification of trabecular bone structure sing magnetic resonance imaging. Bone 17: 417430.
  • 18
    Hipp JA, Jansujwicz A, Simmons CA, Snyder B 1996 Trabecular bone morphology using micro-manetic resonance imaging. J Bone Miner Res 11: 286297.
  • 19
    Jiang Y 1995 Radiology and Histology in the Assessment of Bone Quality. Peeters & Jiang, Leuven, Belgium.
  • 20
    White DL, Schmidlin O, Jiang Y, Zhao J, Majumdar S, Genant HK, Morris RC Jr. 1997 MRI of Trabecular Bone in an Ovariectomized Rat Model of Osteoporosis. International Society for Mangetic Rosonance in Medicine, Vancouver, Canada.
  • 21
    Jiang Y, Zhao J, White DL, Genant HK 2000 Micro CT and micro MR imaging of 3D architecture of animal skeleton. J Musculoskel Neuron Interact 1: 4551.
  • 22
    Farley JR, Tarbaux NM, Hall SL, Linkhart TA, Baylink DJ 1988 The antibone resorptive agent calcitonin also acts in vitro to directly increase bone formation and bone cell proliferation. Endocrinology 123: 159167.
  • 23
    Farley JR, Wergedal JE, Hall SL, Herring S, Tarbaux NM 1991 Calcitonin has direct effects on 3 [H] Thymidine incorporation and alkaline phosphatase activity in human osteoblast-line cells. Calcif Tissue Int 48: 297301.
  • 24
    Hayashi T, Yamamuro T, Okumura H, Kasai R, Tada K 1989 Effect of (Asu1,7)-eel calcitonin on the prevention of osteoporosis in-duced by combination of immobilization and ovariectomy in the rat. Bone 10: 2528.
  • 25
    Wronski TJ, Yen CF, Burton KW, Mehta RC, Newman PS, Soltis EE, DeLuca PP 1991 Skeletal effects of calcitonin in ovarectomized rats. Endocrinology 129: 22462250.
  • 26
    Geusens P, Boonen S, Nijs J, Jiang Y, Lowet G, Van Audekercke R, Huyghe C, Caulin F, Very JM, Dequeker J, Van der Perre G 1996 Effects of salmon calcitonin on femoral bone quality in adult ovariectomized ewes. Calcif Tissue Int 59: 315320.
  • 27
    Gruber HE, Ivey JL, Baylink DJ, Matthews M, Nelp WB, Sisom K, Chesnut CH 1984 Long-term calcitonin therapy in postmenopausal osteoporosis. Metabolism 33: 295303.
  • 28
    Overgaard KY 1994 Effect of intranasal calcitonin therapy on bone mass and bone turnover in early postmenopausal women: A dose response study. Calcif Tissue Int 55: 8286.
  • 29
    Civitelli R, Gonnelli S, Zachei F, Bigazzi S, Vattimo A, Avioli LV, Gennari C 1988 Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment. J Clin Invest 82: 12681274.
  • 30
    Chesnut CH 1995 Drug therapy; calcitonin, bisphosphonates, and anabolic steroids. In: RiggsBL, MeltonLJ (eds.) Osteoporosis: Etiology, Diagnosis and Management. Lippincott-Raven Publishers, Philadelphia, PA, USA.
  • 31
    Kanis JA, Johnell O, Gullberg B, Allander E, Dilsen G, Gennari C, Lopes Vaz AA, Lyritis GP, Mazzuoli G, Miravet L 1992 Evidence for the efficacy of bone active drugs in the prevention of hip fracture. BMJ 305: 11241128.
  • 32
    Ouyang X, Selby K, Lang P, Engelke K, Klifa C, Fan B, Zucconi F, Hottya G, Chen M, Majumdar S, Genant HK 1997 High resolution magnetic resonance imaging of the calcaneus: Age-related changes in trabecular structure and comparison with dual X-ray absorptiometry measurements. Calcif Tissue Int 60: 139147.
  • 33
    Jiang Y, Zhao J, Augat P, Ouyang X, Lu Y, Majumdar S, Genant HK 1998 Trabecular bone mineral and calculated structure of human bone specimens scanned by peripheral quantitative computed tomography: Relation to biomechanical properties. J Bone Miner Res 13: 17831790.
  • 34
    Jiang Y, Zhao J, van Holsbeeck M, Flynn MJ, Ouyang X, Genant HK 2002 Trabecular microstructure and surface changes in the greater tuberosity in rotator cuff tears. Skeletal Radiol 31: 522528.
  • 35
    Durand E, Ruegsegger P 1991 Cancellous bone structure: Analysis of high-resolution CT images with the run-length method. J Comput Assist Tomogr 15: 133139.
  • 36
    Korstjens CM, Geraets WG, van Ginkel FC, Prahl-Andersen B, van der Stelt PF, Burger EH 1995 Longitudinal analysis of radiographic trabecular pattern by image processing. Bone 17: 527532.
  • 37
    Overgaard K, Hansen MA, Jensen B, Christiansen C 1992 Effect of calcitonin given intranasally on bone mass and fracturerates in established osteoporosis: A dose-response study. BMJ 305: 556561.
  • 38
    Ekeland A, Myhre L, Underdale T 1983 Effects of salmon calcitonin on mechanical properties of healing and intact bone and skin in rats. Acta Orthop Scand 54: 462469.
  • 39
    Goldstein SA, Goulet R, McCubbrey D 1993 Measurement and significance of three-dimensional architecture to mechanical integrity of trabecular bone. Calcif Tissue Int 53: S127S133.
  • 40
    Palmieri GMA, Pitcock JA, Brown P, Karas JG, Roen LJ 1989 Effect of calcitonin and vitamin D in osteoporosis. Calcif Tissue Int 45: 137141.
  • 41
    Kroger H, Arnala I, Alhava EM 1992 Effect of calcitonin on bone histomorphometry and bone metabolism in rheumatoid arthritis. Calcif Tissue Int 50: 1113.
  • 42
    Grynpass MD, Acito A, Dimitriu M, Mertz BP, Very JM 1992 Changes in bone mineralization, architecture and mechanical properties due to long-term (1 year) administration of pamidronate (APD) to adult dogs. Osteoporos Int 2: 7481.
  • 43
    Takagi Y, Fujii Y, Miyauchi A, Goto B, Takahashi K, Fujita T 1995 Transmenopausal change of trabecular bone density and structural pattern assessed by peripheral quantitative computed tomography in Japanese women. J Bone Miner Res 10: 18301834.
  • 44
    Chevalier F, Laval-Jeantet A, Laval-Jeantet M, Bergot C 1992 CT image analysis of the vertebral trabecular network in vivo. Calcif Tissue Int 51: 813.
  • 45
    Majumdar S, Genant HK, Grampp S, Newitt DC, Truong VH, Lin JC, Mathur A 1997 Correlation of trabecular bone structure with age, bone mineral density, and osteoporotic status: In vivo studies in the distal radius using high resolution magnetic resonance imaging. J Bone Miner Res 12: 111118.
  • 46
    Carter DR, Hayes WC 1977 The compressive behavior of bone as a two-phase porous structure. J Bone Joint Surg Am 59A: 954962.
  • 47
    Vesterby A, Mosekilde L, Gundersen HJ, Melsen F, Mosekilde L, Holme K, Sorensen S 1991 Biologically meaningful determinants of the in vitro strength of lumbar vertebrae. Bone 12: 219224.
  • 48
    Dalstra M, Huiskes A, Odgaard EV 1993 Mechanical and textural properties of pelvic trabecular bone. J Biomech 27: 375.